Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Clinical trial NCT03808337 · RECRUITING

Trial details

NCT number: NCT03808337
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Non Small Cell Lung Cancer Metastatic Breast Cancer Metastatic Non-Small Cell Lung Carcinoma

Start date: 2019-01-16
Primary completion: 2027-01-01
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.